New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
C21 Investments Inc.
CXXI.CN
Shape
US Flag

CNQ

Unprofitable

Unprofitable

38M

Drug Manufacturers - Specialty & Generic

Next Earning date - 21 Oct 2024

38M

Drug Manufacturers - Specialty & Generic

Next Earning date - 21 Oct 2024

0.32CAD
Shape-0.01 ( -1.54%)
Market Open
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

11%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

50%

Quote Panel

Shape
Updated October 21, 2024
1W 1.59 % 1M 1.59 % 3M -12.33 % 1Y -5.88 %

Key Metrics

Shape
  • Market Cap

    38.42M


  • Shares Outstanding

    120.05M


  • Share in Float

    97.13M


  • Dividende

    0


  • Earning Date

    21 Oct 2024


  • Price Target

    0.32


  • Average Volume

    28832


  • Beta

    2.301


  • Range

    0.265-0.64


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.cxxi.ca


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

1.02x

P/S Ratio

0.90x

P/B Ratio

0.4

Debt/Equity

-15.6%

Net Margin

$-0.0

EPS

How CXXI.CN compares to sector?

P/E Ratio

Relative Strength

Shape

CXXI.CN

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

No Data Available

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

N/A

-0.00
vs -0.07

Q2.22

arrow
arrow

-94%

0
vs 0.05

Q3.22

arrow
arrow

-48%

0.02
vs 0.04

Q4.22

arrow
arrow

N/A

-0.02
vs 0.03

Q1.23

arrow
arrow

N/A

NA
vs -0.00

Q2.23

arrow
arrow

N/A

-0.01
vs 0

Q3.23

arrow
arrow

N/A

-0.00
vs 0.02

Q4.23

arrow
arrow

N/A

-0.00
vs -0.02

Q1.24

arrow
arrow

N/A

-0.02
vs NA

Q2.24

arrow
arrow

N/A

-0.02
vs -0.01

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

-27%

6.7M  vs 9.1M

Q2.22

arrow
arrow

-18%

7.5M  vs 9.2M

Q3.22

arrow
arrow

-20%

7.2M  vs 9M

Q4.22

arrow
arrow

-12%

7.2M  vs 8.2M

Q1.23

arrow
arrow

+5%

7M  vs 6.7M

Q2.23

arrow
arrow

+3%

7.7M  vs 7.5M

Q3.23

arrow
arrow

0%

7.2M  vs 7.2M

Q4.23

arrow
arrow

-5%

6.9M  vs 7.2M

Q1.24

arrow
arrow

-7%

6.5M  vs 7M

Q2.24

arrow
arrow

-14%

6.6M  vs 7.7M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

+5%

0.05
vs 0.01

Q4.22

arrow
arrow

+1%

0.01
vs 0.05

Q1.23

arrow
arrow

-6%

-0.06
vs 0.01

Q2.23

arrow
arrow

-1%

-0.01
vs -0.06

Q3.23

arrow
arrow

-1%

-0.01
vs -0.01

Q4.23

arrow
arrow

-1%

-0.01
vs -0.01

Q1.24

arrow
arrow

-7%

-0.07
vs -0.01

Q2.24

arrow
arrow

-5%

-0.05
vs -0.07

Institutionnal OwnershipShape

status-up

Earnings Growth

Latest News